65,437 trials
Chronic Obstructive Pulmonary Disease (COPD)
Primary: 24-hour Post-dose Trough Forced Expiratory Volume in 1 Second (FEV1) After 14 Days of Treatment — 1.53; 1.51; 1.48; 1.36 Liters
Infection, Human Immunodeficiency Virus I · HIV Infection
Primary: Percentage of Participants (PAR) Who Achieved Plasma HIV-1 RNA <50 Copies (c) /Milliliter (ml) at the Week 84 Visit — 86; 81 percentage of participants — p=0.140
Breast Cancer
Primary: Participants Experiencing Dose Limiting Toxicity (DLT) — 0; 0; 0 Participants
Chronic Obstructive Pulmonary Disease (COPD)
Primary: Trough Forced Expiratory Volume in 1 Second (FEV1) Following 14 Days of Evening Dosing of Indacaterol Versus Placebo — 1.57; 1.37 Liters
Chronic Obstructive Pulmonary Disease (COPD)
Primary: Trough Forced Expiratory Volume in 1 Second (FEV1) at Week 12 + 1 Day, Day 85 — 1.32; 1.29; 1.17 Liters
Chronic Obstructive Pulmonary Disease
Primary: Forced Expiratory Volume in 1 Second (FEV1) Standardized (With Respect to Time) Area Under the Curve (AUC) From 22 to 24 Hours Post-dose on Day 2 — 1.49; 1.48; 1.45…
Spinal Stenosis
Primary: Mean Percentage Change in Symptom Severity at 6 Weeks Compared to Baseline, Using the Patient Completed Zurich Claudication Questionnaire for Symptom Severity — -29.7…
Persistent Asthma
Primary: Change From Baseline in the Trough Forced Expiratory Volume in One Second (FEV1) After Two Weeks of Treatment — 0.156; 0.197; 0.199; -0.005 Liters
Asthma
Primary: Forced Expiratory Volume in 1 Second (FEV1) Standardized (With Respect to Time) Area Under the Curve (AUC) From 22 to 24 Hours Post-dose on Day 2 — 2.31; 2.28; 2.24…
Diabetes Mellitus Type 2
Primary: Safety and Tolerability of EGT0001474 — 5; 0; 9; 3 Events
Chronic Obstructive Pulmonary Disease
Primary: Exercise Duration Time Assessed by Constant-load Cycle Ergometry at the End of Each Treatment Period — 586; 475 Seconds
Healthy
Primary: Number of Days Children Are Out of School Sick — 2.51; 2.82 days per 100 person days
Chronic Obstructive Pulmonary Disease (COPD)
Primary: Trough Forced Expiratory Volume in 1 Second (FEV1) 24 Hours Post-dose at the End of Treatment (Week 12 + 1 Day, Day 85) — 1.34; 1.37; 1.17 Liters
Chronic Obstructive Pulmonary Disease
Primary: Forced Expiratory Volume in 1 Second (FEV1) at 5 Minutes Post-dose — 1.48; 1.50; 1.38; 1.43 Liters
Barrett's Esophagus · Esophageal Adenocarcinoma
Primary: Diagnostic Yield for Neoplasia in High Risk Patients(Suspected Neoplasia) — 34; 17 percent yield for neoplasia — p=0.01